Citation 16638

SETHI,VS:. (1977). BASE SPECIFICITY IN THE INHIBITION OF ONCORNAVIRUS REVERSE TRANSCRIPTIONS AND CELLULAR NUCLEIC ACID POLYMERASES BY ANTITUMOR DRUGS.. 284()

Citation Details

Title	BASE SPECIFICITY IN THE INHIBITION OF ONCORNAVIRUS REVERSE TRANSCRIPTIONS AND CELLULAR NUCLEIC ACID POLYMERASES BY ANTITUMOR DRUGS.
Authors	SETHI,VS:
Year	1977
Volume	284
Issue

Summary

Year: 1977

Journal: Unknown

Organisms and Their Experiments (4)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ADRIAMYCINDAUNORUBICIN	ACTIVE
2	RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ADRIAMYCINDAUNORUBICIN	ACTIVE
3	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ADRIAMYCINDAUNORUBICIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORALYNE*	ACTIVE
2	RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORALYNE*	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORALYNE*	ACTIVE

Zanthoxylum gillettii (RUTACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NITIDINE	ACTIVE
2	RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NITIDINE	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NITIDINE	ACTIVE

Fagara zanthoxyloides (RUTACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FAGARONINE	ACTIVE
2	RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FAGARONINE	ACTIVE
3	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FAGARONINE	ACTIVE

Show SPARQL Queries (1)